Natural frequencies are important dynamic characteristics of a structure where they are required for the forced vibration analysis and solution of resonant response. Therefore, the exact solution to ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The planned closure of Bio Palette has triggered the termination of a deal that gave Beam Therapeutics rights to base editing technology. Having prepared for that outcome, Beam has retained access to ...

Almost exactly a year ago to the day, Pfizer withdrew the hemophilia B gene therapy Beqvez from the market and ended all work on it. Now, the pharma wants back in the genetics game, inking a global ...

After dumping its sole remaining gene therapy asset last year, Pfizer has decided to exercise its option for global rights to Beam Therapeutics’ liver-targeted gene editing candidate. The agreement, ...

is a deputy editor and Verge co-founder with a passion for human-centric cities, e-bikes, and life as a digital nomad. He’s been a tech journalist for 20 years. Light-based internet provider Taara, ...

PORTLAND, Ore. — At a work session Tuesday morning, Multnomah County commissioners deliberated over potential changes to the county's drug deflection regime, a response to the program's lackluster ...

Good afternoon. Thank you for joining us for another session at the 44th JPMorgan Healthcare Conference. I'm Brian Cheng, one of the senior biotech analysts here at the firm. On stage, we have the CEO ...

Beam has reported progress with the FDA on a potential accelerated approval path for BEAM‑302 and plans to file a Biologics License Application (BLA) for risto‑cel as early as the end of 2026. Beam ...